Journal of Experimental Medicine

The Journal of Experimental Medicine is a peer-reviewed academic journal published by the Rockefeller University Press that publishes research papers and commentaries on the physiological, pathological, and molecular mechanisms that encompass the host response to disease. The journal prioritizes studies on intact organisms and has made a commitment to publishing studies on human subjects. Topics covered include immunology, inflammation, infectious disease, hematopoiesisas, cancer, stem cells and vascular biology. The JEM is second highest (based on impact factor) among the journals that publish basic research articles from all fields of biomedicine. Among all biomedical journals (specialized or nonspecialized) JEM stands among the top 10. The JEM was founded in 1896 at the Johns Hopkins School of Medicine by William H. Welch, the school’s founder and also the first president of the Board of Scientific Directors of the Rockefeller Institute (since re-named the Rockefeller University). From its inception, Welch edited the journal by himself—even editing manuscripts while attending baseball games—and he eventually found that it placed too heavy a burden on his time. By March 1902, the

Publisher
Rockefeller University Press
Country
United States
History
1896–present
Impact factor
14.776 (2010)
Some content from Wikipedia, licensed under CC BY-SA

B-cells aggravate autoimmune diseases

Scientists in Freiburg may have discovered a fundamental aggravating factor in autoimmune diseases. If B-lymphocytes lack the protein PTP1B, the cells will become hyperactive for stimulatory signals and can ...

Mar 04, 2014
popularity 5 / 5 (2) | comments 0

Gut microbes spur development of bowel cancer

It is not only genetics that predispose to bowel cancer; microbes living in the gut help drive the development of intestinal tumors, according to new research in mice published in the March issue of The Jo ...

Mar 03, 2014
popularity 5 / 5 (10) | comments 0

Killer cocktail fights brain cancer

A novel immune-boosting drug combination eradicates brain cancer in mice, according to a study in The Journal of Experimental Medicine.

Nov 25, 2013
popularity 5 / 5 (1) | comments 0

New immuno-therapy for malignant brain tumors

Animal experiments show that it is relatively easy to treat cancer in the early stages. However, it is far more difficult to successfully treat advanced cancer. Treatment of brain tumors is particularly challenging because ...

Nov 25, 2013
popularity 5 / 5 (1) | comments 0